RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $378
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix maintains an Outperform rating on HCA Healthcare (NYSE:HCA) and raises the price target from $329 to $378.
July 24, 2024 | 4:25 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Ben Hendrix maintains an Outperform rating on HCA Healthcare and raises the price target from $329 to $378.
The raised price target and maintained Outperform rating from RBC Capital are positive signals for HCA Healthcare, likely boosting investor confidence and potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100